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family members or visitors. No correlation was found between 
isolates recovered from routine surveillance cultures done for 
patients and isolates found to be colonizing or contaminating 
patients' family members or visitors. 
The duration of family visits in our ICU (3 or more hours 
per day) is no shorter than the visiting times reported in other 
countries.5'7'8 In addition, 18 of 33 patients had a length of stay 
of 15 days or more. Thus, limited exposure time is not a good 
explanation for the lack of correlation between isolates recov-
ered from patients and isolates recovered from their respective 
family members and visitors. 
Hand washing is recommended as the most effective means 
to prevent transmission by direct contact, because it reduces 
the concentration of contaminants on the skin.9 We did detect 
contamination with A. baumanii on the hands of visitors prior 
to hand washing at departure, an organism that was also iso-
lated from the patients that they visited. After that, these visi-
tors were monitored for the presence of A. baumanii prior to 
entry to the ICU and after hand washing; A. baumanii was not 
isolated again from these individuals. We believe the lack of 
correlation between the isolates recovered from patients and 
those recovered from family members may relate to our hand 
washing policies. 
Fumagalli et al.4 have shown that an unrestricted visitation 
policy, despite imposing a greater microbial burden and 
greater environmental contamination, does not increase the 
risk of infectious complications'in cardiac ICU patients. Po-
tential pathogens isolated from patients do not appear to be the 
same as those carried by their family members and visitors, nor 
does exposure to these pathogens increase the risk of infection 
in the ICU if appropriate hand hygiene is enforced. 
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Whole-Blood Interferon-Gamma Release 
Assay for Baseline Tuberculosis Screening 
of Healthcare Workers at a Swiss 
University Hospital 
To the Editor—In countries with low tuberculosis incidence 
rates, such as Switzerland,1 targeted testing for latent tubercu-
losis infection (LTBI) among risk groups such as healthcare 
workers (HCWs) is an important measure for preventing tu-
berculosis disease.24 We studied the prevalence of LTBI and its 
risk factors among hospital employees at the University Hos-
pital of Berne, Switzerland, in a retrospective cohort study us-
ing a whole-blood interferon-gamma release assay (IGRA).5 
From June 1, 2005, through May 31, 2006, we screened 777 
employees for tuberculosis infection with an IGRA on com-
mencement of employment. The following data were collected 
for each HCW: age, sex, bacille Calmette-Guerin (BCG) vacci-
nation status (documented or reported), country of origin, 
place of work, and profession. The mean age of subjects was 32 
years (75% were aged 20-40 years). The majority (70.8%) of 
employees were female (Table). The overall BCG vaccination 
rate was 87.4% (90.4% among employees of Swiss origin, of 
whom 12.1% had multiple BCG vaccinations). The IGRA used 
for screening (QuantiFeron-TB Gold In-Tube assay; Cellestis) 
was performed according to the manufacturer's instructions.6 
Data were evaluated by univariate analysis as well as multiple 
logistic regression analysis. GraphPad Prism 4, version 4.01 
(GraphPad Software), and StatView, version 5.0 (SAS Insti-
tute), were used for all data evaluations. 
A positive IGRA result was found for 59 (7.6%) of the 777 
participants (Table). Tuberculosis disease was ruled out in 
each case by a careful consideration of the medical history, the 
symptoms, and the chest X-ray findings. The overall rate of 
LTBI in our study population was 7.6%, which concurs with 
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T A B L E . Results of Univariate Analysis of Risk Factors for Latent Tuberculosis (TB) Infection Among 777 
Healthcare Workers (HCWs) Screened 
Factor 
Age, years, mean ± SD 
Sex 
Female 
Male 
Country of origin, by 
incidence of TBa 
Group A (low) 
Group B (high) 
Degree of risk of 
exposure to TB 
By place of work 
Low 
Moderate 
High 
By profession 
Low 
Moderate 
High 
Receipt of BCG 
vaccination 
No 
Yes 
Unknown 
No. (%) of 
all HCWs 
550 (70.8) 
227 (29.2) 
682 (87.8) 
95 (12.2) 
217 (27.9) 
398 (51.2) 
162 (20.8) 
221 (28.4) 
198 (25.5) 
358(46.1) 
63 (8.1) 
428 (55.1) 
286 (36.8) 
No. (%) of HCWs with risk 
factor, by 
Positive 
(n = 59) 
33.7 ± 11.1 
44 (8.0) 
15 (6.6) 
41 (6.0) 
18(18.9) 
11 (5.0) 
30 (7.5) 
18(11.1) 
15 (6.8) 
14 (7.0) 
30 (8.4) 
6 (9.5) 
28 (6.5) 
25 (8.7) 
IGRA result 
Negative 
(n = 718) 
31.6 ± 9.6 
506 (92.0) 
212 (93.4) 
641 (94.0) 
77(81.1) 
206 (95.0) 
368 (92.5) 
144 (88.9) 
206 (93.2) 
184 (93.0) 
328 (91.6) 
57 (90.5) 
400 (93.5) 
261 (91.3) 
Odds ratio 
(95% CI) 
1.02 (0.99-1.04) 
0.81 (0.44-1.49) 
3.65 (2.00-6.67) 
1.52(0.74-3.11) 
2.34(1.07-5.10) 
1.04 (0.49-2.22) 
1.25 (0.66-2.39) 
0.66 (0.26-1.67) 
P 
.10 
.50 
<.001 
.03b 
.24 
.03 
.46d 
.91 
.49 
.39 
NOTE. BCG, Bacille Calmette-Guerin; CI, confidence interval; IGRA, interferon-'y release assay. 
a
 The cutoff for TB incidence was 10 cases per 100,000 population (see text for details). Patients in Group A originated in 
Germany, Switzerland, Finland, Denmark, the Netherlands, Sweden, and the United States. Patients in Group B origi-
nated in Algeria, Argentina, Austria, Bosnia and Herzegovina, Brazil, Czech Republic, Dominican Republic, Egypt, 
Ethiopia, Great Britain, Greece, Croatia, Hungary, India, Iran, Iraq, Japan, Republic of Korea, Sri Lanka, Luxemburg, the 
former Yugoslav Republic of Macedonia, Philippines, Poland, Portugal, Russian Federation, Serbia and Montenegro, 
Sudan, Senegal, Spain, Thailand, Tunisia, Turkey, Uruguay, Viet Nam, and Yemen. 
b
 By the x2 test for trend. 
published data for countries with an incidence of tuberculosis 
comparable to that of Switzerland. A recent German study7 
found positive IGRA results for 25 (9.6%) of 261 participants. 
There was no association between the IGRA result and pro-
fession, age, or sex (Table). Employees were stratified for risk of 
LTBI into 2 groups, according to their country of origin. An 
annual incidence of tuberculosis disease of 10 cases per 100,000 
population was chosen as the cutoff1; employees from a coun-
try with a higher rate were placed in group B, and all other 
participants were placed in group A. The IGRA positivity rate 
for employees from group A was 6.0%; the rate was 18.9% for 
employees from group B. There was a statistically significant 
positive association between a positive IGRA result and mem-
bership in group B (odds ratio [OR], 3.65 [95% confidence 
interval {CI}, 2.0-6.7]; P < .001). 
The work place-associated risk of contracting tuberculosis 
was distributed as follows among the HCWs screened: low risk, 
217 HCWs (27.9%); moderate risk, 398 (51.2%); high risk, 162 
(20.8%) (Table). The work places considered to have a high 
risk were the Departments of Thoracic Surgery, Pneumology, 
Rheumatology, Infectious Diseases, Anesthesiology, Intensive 
Care, and Emergency Medicine. Nonmedical places of work, 
such as the laundry, the restaurant, the main office, and the 
administrative office, were considered to have low risk. 
The high-risk category of professions was considered to 
comprise nurses, physiotherapists, radiographers, and mem-
bers of the maintenance, cleaning, and transportation services. 
All other HCWs, such as medical doctors or social workers, 
were considered to be in the moderate-risk category. Profes-
sions without direct patient contact, such as secretaries, com-
puter and technical specialists, scientists, pharmacists, and se-
curity staff, were considered to have low risk. 
The IGRA positivity rate was 5.0% for HCWs who worked in 
low-risk work places, 7.5% for HCWs in moderate-risk work 
places, and 11.1% for HCWs in high-risk work places (Table). 
We detected a statistically significant trend for association of a 
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positive IGRA result with work in a place with a high risk (x2 
test for trend, P = .029). Both the country of origin and place of 
work were independent risk factors associated with a positive 
IGRA result, according to multiple logistic regression analysis. 
For employees originating from a group B country, the OR was 
3.65 (95% CI, 2.00-6.67); the P value was less than .001. For 
employees working at a place with a high risk of tuberculosis 
exposure, the OR was 2.34 (95% CI, 1.07-5.10); thePvalue was 
.03. 
Our findings are consistent with reports by other groups. A 
Japanese study8 found no association between the IGRA result 
and the profession of the subjects tested. An analysis of infec-
tion risk related to the place of work was not done, however. A 
recently published German study9 reported an increased infec-
tion risk for HCWs engaged in geriatric care, but this study 
included no other hospital units. It can be argued that "place of 
work" is a surrogate for risk of exposure to contagious tuber-
culosis related to particular patient populations, whereas "pro-
fession" represents the intensity of contact during patient care. 
Since infectious tuberculosis is highly contagious, the latter 
may not be as important as the risk of being exposed at all. The 
place of work therefore seems to be a better surrogate than 
profession for the risk of contracting tuberculosis infection. In 
contrast to our study, both the Japanese and the German stud-
ies8,9 reported a strong association between a positive IGRA 
result and increasing age among HCWs. The narrow age dis-
tribution in our study population (mean ± SD, 32 ± 9.7 years) 
might have reduced our ability to detect such an association. 
(In the German study, the mean age [±SD] was 40.0 ± 10.4 
years9; in the Japanese study, it was 41.4 ± 11.2 years.8) 
In conclusion, the IGRA was a useful tool for baseline 
screening for LTBI in this population of HCWs with a high 
background of BCG vaccination. Hospital employees had a 
measurable extra risk of tuberculosis infection that was associ-
ated with certain places of work and with their country of ori-
gin but not with their profession. 
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